Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-02-07 Sale |
2024-02-09 5:43 pm |
Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel |
29,835 | $20 | $596,805 | 299,357 (Direct) |
View |
| 2024-02-07 Sale |
2024-02-09 5:42 pm |
Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer |
10,000 | $20.03 | $200,258 | 456,271 (Direct) |
View |
| 2024-01-23 Sale |
2024-01-25 4:46 pm |
Edgewise Therapeutics Inc. | EWTX | Carruthers R Michael Chief Financial Officer |
90,000 | $15.78 | $1,419,759 | 166,082 (Direct) |
View |
| 2024-01-23 Purchase |
2024-01-25 4:32 pm |
Edgewise Therapeutics Inc. | EWTX | Thompson Peter A. Director 10% Owner |
454,545 | $11 | $4,999,995 | 14,756,096 (Indirect) |
View |
| 2024-01-23 Purchase |
2024-01-25 4:28 pm |
Edgewise Therapeutics Inc. | EWTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC Director 10% Owner |
454,545 | $11 | $4,999,995 | 14,756,096 (Indirect) |
View |
| 2023-12-26 Purchase |
2023-12-28 4:39 pm |
Edgewise Therapeutics Inc. | EWTX | Fox Jonathan C Director |
10,857 | $9.2989 | $100,958 | 10,857 (Direct) |
View |
| 2023-12-27 Sale |
2023-12-28 4:39 pm |
Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel |
8,497 | $10.5 | $89,219 | 0 (Direct) |
View |
| 2023-12-26 Sale |
2023-12-28 4:38 pm |
Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer |
172,585 | $9.3293 | $1,610,097 | 3,606 (Direct) |
View |
| 2023-05-02 Sale |
2023-05-03 6:26 pm |
Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer |
1,747 | $8.9049 | $15,557 | 17,437 (Direct) |
View |
| 2023-05-02 Sale |
2023-05-03 6:26 pm |
Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel |
1,897 | $8.9049 | $16,893 | 16,982 (Direct) |
View |
| 2023-05-02 Sale |
2023-05-03 6:26 pm |
Edgewise Therapeutics Inc. | EWTX | Carruthers R Michael Chief Financial Officer |
1,336 | $8.9049 | $11,897 | 26,543 (Direct) |
View |
| 2023-05-02 Sale |
2023-05-03 6:26 pm |
Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer |
1,602 | $8.9049 | $14,266 | 186,608 (Direct) |
View |
| 2023-05-02 Sale |
2023-05-03 6:25 pm |
Edgewise Therapeutics Inc. | EWTX | Donovan Joanne M. CMO |
3,254 | $8.9049 | $28,977 | 30,794 (Direct) |
View |
| 2023-05-02 Sale |
2023-05-03 6:25 pm |
Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO |
3,203 | $8.9049 | $28,522 | 366,831 (Indirect Direct) |
View |
| 2022-10-03 Sale |
2022-10-05 4:42 pm |
Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel |
4,730 | $9.7579 | $46,155 | 125,997 (Direct) |
View |
| 2022-09-16 Purchase |
2022-09-16 4:34 pm |
Edgewise Therapeutics Inc. | EWTX | Thompson Peter A. Director 10% Owner |
484,496 | $10.32 | $4,999,999 | 14,301,551 (Indirect) |
View |
| 2022-09-16 Purchase |
2022-09-16 4:31 pm |
Edgewise Therapeutics Inc. | EWTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC Director 10% Owner |
484,496 | $10.32 | $4,999,999 | 14,301,551 (Indirect) |
View |
| 2022-09-14 Purchase |
2022-09-16 2:35 pm |
Edgewise Therapeutics Inc. | EWTX | Novo Holdings A/S 10% Owner |
484,496 | $10.32 | $4,999,999 | 6,071,703 (Direct) |
View |
| 2022-09-06 Sale |
2022-09-08 4:16 pm |
Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel |
4,730 | $10.91 | $51,598 | 130,727 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-02-07 Exercise |
2024-02-09 5:43 pm |
N/A 2030-12-15 |
Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel |
29,835 | $0 | 299,357 (Direct) |
View |
| 2024-02-07 Exercise |
2024-02-09 5:43 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel |
29,835 | $1.93 | 299,357 (Direct) |
View |
| 2024-02-07 Exercise |
2024-02-09 5:42 pm |
N/A 2030-12-15 |
Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer |
10,000 | $0 | 456,271 (Direct) |
View |
| 2024-02-07 Exercise |
2024-02-09 5:42 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer |
10,000 | $1.93 | 456,271 (Direct) |
View |
| 2024-01-23 Exercise |
2024-01-25 4:46 pm |
N/A 2030-12-15 |
Edgewise Therapeutics Inc. | EWTX | Carruthers R Michael Chief Financial Officer |
90,000 | $0 | 166,082 (Direct) |
View |
| 2024-01-23 Exercise |
2024-01-25 4:46 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | Carruthers R Michael Chief Financial Officer |
90,000 | $1.93 | 166,082 (Direct) |
View |
| 2023-08-17 Option Award |
2023-08-18 7:13 pm |
N/A 2033-08-17 |
Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer |
220,000 | $0 | 220,000 (Direct) |
View |
| 2023-08-17 Option Award |
2023-08-18 7:13 pm |
N/A 2033-08-17 |
Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel |
200,000 | $0 | 200,000 (Direct) |
View |
| 2023-08-17 Option Award |
2023-08-18 7:13 pm |
N/A 2033-08-17 |
Edgewise Therapeutics Inc. | EWTX | Carruthers R Michael Chief Financial Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2023-08-17 Option Award |
2023-08-18 7:13 pm |
N/A 2033-08-17 |
Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2023-08-17 Option Award |
2023-08-18 7:13 pm |
N/A 2033-08-17 |
Edgewise Therapeutics Inc. | EWTX | Semigran Marc Chief Development Officer |
133,333 | $0 | 133,333 (Direct) |
View |
| 2023-08-17 Option Award |
2023-08-18 7:13 pm |
N/A 2033-08-17 |
Edgewise Therapeutics Inc. | EWTX | Donovan Joanne M. CMO |
200,000 | $0 | 200,000 (Direct) |
View |
| 2023-08-17 Option Award |
2023-08-18 7:12 pm |
N/A 2033-08-17 |
Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO |
600,000 | $0 | 600,000 (Direct) |
View |
| 2023-06-22 Exercise |
2023-06-26 4:28 pm |
N/A 2030-09-01 |
Edgewise Therapeutics Inc. | EWTX | Carruthers R Michael Chief Financial Officer |
10,000 | $0 | 226,146 (Direct) |
View |
| 2023-06-22 Exercise |
2023-06-26 4:28 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | Carruthers R Michael Chief Financial Officer |
10,000 | $0.71 | 226,146 (Direct) |
View |
| 2023-06-12 Option Award |
2023-06-14 7:30 pm |
2024-06-12 2033-06-12 |
Edgewise Therapeutics Inc. | EWTX | Fox Jonathan C Director |
22,123 | $0 | 22,123 (Direct) |
View |
| 2023-06-12 Option Award |
2023-06-14 7:29 pm |
2024-06-12 2033-06-12 |
Edgewise Therapeutics Inc. | EWTX | Thompson Peter A. Director 10% Owner |
22,123 | $0 | 22,123 (Direct) |
View |
| 2023-06-12 Option Award |
2023-06-14 7:29 pm |
2024-06-12 2033-06-12 |
Edgewise Therapeutics Inc. | EWTX | ROOT JONATHAN D Director |
22,123 | $0 | 22,123 (Direct) |
View |
| 2023-06-12 Option Award |
2023-06-14 7:29 pm |
2024-06-12 2033-06-12 |
Edgewise Therapeutics Inc. | EWTX | Edris Badreddin Director |
22,123 | $0 | 22,123 (Direct) |
View |
| 2023-06-12 Option Award |
2023-06-14 7:29 pm |
2024-06-12 2033-06-12 |
Edgewise Therapeutics Inc. | EWTX | Brege Laura Director |
22,123 | $0 | 22,123 (Direct) |
View |
| 2023-05-01 Exercise |
2023-05-03 6:26 pm |
N/A 2032-05-01 |
Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer |
5,208 | $0 | 17,437 (Direct) |
View |
| 2023-05-01 Exercise |
2023-05-03 6:26 pm |
N/A 2032-05-01 |
Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel |
5,208 | $0 | 16,982 (Direct) |
View |
| 2023-05-01 Exercise |
2023-05-03 6:26 pm |
N/A 2032-05-01 |
Edgewise Therapeutics Inc. | EWTX | Carruthers R Michael Chief Financial Officer |
5,208 | $0 | 26,543 (Direct) |
View |
| 2023-05-01 Exercise |
2023-05-03 6:26 pm |
N/A 2032-05-01 |
Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer |
5,208 | $0 | 186,608 (Direct) |
View |
| 2023-05-01 Exercise |
2023-05-03 6:25 pm |
N/A 2032-05-01 |
Edgewise Therapeutics Inc. | EWTX | Donovan Joanne M. CMO |
10,416 | $0 | 30,794 (Direct) |
View |
| 2023-05-01 Exercise |
2023-05-03 6:25 pm |
N/A 2032-05-01 |
Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO |
10,416 | $0 | 366,831 (Direct) |
View |
| 2023-03-03 Option Award |
2023-03-07 5:59 pm |
N/A 2033-03-03 |
Edgewise Therapeutics Inc. | EWTX | Fox Jonathan C Director |
43,731 | $0 | 43,731 (Direct) |
View |
| 2022-12-30 Option Award |
2023-01-03 4:44 pm |
N/A 2032-12-30 |
Edgewise Therapeutics Inc. | EWTX | Semigran Marc Chief Development Officer |
300,000 | $0 | 300,000 (Direct) |
View |
| 2022-10-03 Exercise |
2022-10-05 4:42 pm |
N/A 2030-12-15 |
Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel |
4,730 | $0 | 125,997 (Direct) |
View |
| 2022-10-03 Exercise |
2022-10-05 4:42 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel |
4,730 | $1.93 | 125,997 (Direct) |
View |
| 2022-09-06 Exercise |
2022-09-08 4:16 pm |
N/A 2030-12-15 |
Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel |
4,730 | $0 | 130,727 (Direct) |
View |
| 2022-09-06 Exercise |
2022-09-08 4:16 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel |
4,730 | $1.93 | 130,727 (Direct) |
View |
| 2022-08-08 Option Award |
2022-08-10 5:43 pm |
N/A 2032-08-08 |
Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel |
200,000 | $0 | 200,000 (Direct) |
View |
| 2022-08-08 Option Award |
2022-08-10 5:42 pm |
N/A 2032-08-08 |
Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer |
220,000 | $0 | 220,000 (Direct) |
View |
| 2022-08-08 Option Award |
2022-08-10 5:42 pm |
N/A 2032-08-08 |
Edgewise Therapeutics Inc. | EWTX | Carruthers R Michael Chief Financial Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2022-08-08 Option Award |
2022-08-10 5:42 pm |
N/A 2032-08-08 |
Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer |
200,000 | $0 | 200,000 (Direct) |
View |